<!DOCTYPE html>
<html>
	<head>
	 <meta charset="UTF-8">
	 <meta name="description" content="This is an awesome website!">
	<title>Bill's BioPharma Watch</title>
	</head>
	<body style="background-color:lightblue;">
<h1 align="center">Bill's BioPharma Watch</h1>
  <a href="index.html" >Home</a>
	<a href="About.html" >About</a>
	<a href="September.html" >September</a>
	<a href="October.html" >October</a>
	<a href="November.html" >November</a>
	<a href="December.html" >December</a>
  <a href="WatchList.html">WatchList</a>
<hr>




<p align="center">
		<img src="ddecemjpg.jpg" />

<h1 align="center">BIOCRYST PHARMACEUTICALS INC</h1>

<!-- TradingView Widget BEGIN -->
<div class="tradingview-widget-container">
<div class="tradingview-widget-container__widget"></div>
<div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/NASDAQ-BCRX/" rel="noopener" target="_blank"><span class="blue-text">BCRX Symbol Info</span></a> by TradingView</div>
<script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-info.js" async>
{
"symbol": "NASDAQ:BCRX",
"width": 1000,
"locale": "en",
"colorTheme": "light",
"isTransparent": false
}
</script>
</div>
<!-- TradingView Widget END -->

<p><b>B</b>ioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor,
  for the treatment of acute uncomplicated influenza under the RAPIVAB, ALPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral
  T-cell lymphoma. It is also developing BCX7353, an oral serine protease inhibitor and oral dose formulation that is in Phase III clinical trials to treat hereditary angioedema; BCX9930,
  an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in preclinical trials to treat
  fibrodysplasia ossificans progressive; and Galidesivir, an RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever,
  Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Seqirus UK
  Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of
  Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina. <i>Source Fidelity.com</i>

</p>

  <dl>
    <dt><b>BCRX PDUFA Dates</b></dt>
      <dd>December 12th</dd>
  </dl>


    <h1>Research Links</h1>

  <p><a href="https://www.biocryst.com/" target="_blank" >Company Website</a></p>
  <p><a href="https://finance.yahoo.com/quote/BCRX?p=BCRX" target="_blank">Yahoo Fiance</a></p>
  <p><a href="https://stocktwits.com/symbol/BCRX" target="_blank">StockTwits</a></p>
  <p><a href="https://www.tradingview.com/symbols/NASDAQ-BCRX/?utm_campaign=mini-symbol-overview&utm_medium=widget_new" target="_blank">TradingView</a></p>
  <p><a href="https://www.biopharmcatalyst.com/" target="_blank">BioPharmCatalyst.com</a></p>

<p><hr></p>

<h1 align="center">VANDA PHARMACEUTICALS INC</h1>


<div class="tradingview-widget-container">
  <div class="tradingview-widget-container__widget"></div>
  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/NASDAQ-VNDA/" rel="noopener" target="_blank"><span class="blue-text">VNDA Symbol Info</span></a> by TradingView</div>
  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-info.js" async>
  {
  "symbol": "NASDAQ:VNDA",
  "width": 1000,
  "locale": "en",
  "colorTheme": "light",
  "isTransparent": false
}
  </script>
</div>


<p><b>V</b>anda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products
	include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone
	deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor
	partial agonist for the treatment of psychiatric disorders; and a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and
	ocular inflammation, as well as for the treatment of secretory diarrhea disorders, including cholera. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals
	Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia. <i>Source Fidelity.com</i>

</p>

  <dl>
    <dt><b>VNDA PDUFA Dates</b></dt>
      <dd>December 1st</dd>
  </dl>


    <h1>Research Links</h1>

  <p><a href="https://www.vandapharma.com/" target="_blank" >Company Website</a></p>
  <p><a href="https://finance.yahoo.com/quote/VNDA?p=VNDA" target="_blank">Yahoo Fiance</a></p>
  <p><a href="https://stocktwits.com/symbol/VNDA" target="_blank">StockTwits</a></p>
  <p><a href="https://www.tradingview.com/symbols/NASDAQ-VNDA/?utm_campaign=mini-symbol-overview&utm_medium=widget_new" target="_blank">TradingView</a></p>
  <p><a href="https://www.biopharmcatalyst.com/" target="_blank">BioPharmCatalyst.com</a></p>



	</body>
</html>
